Symmetric Antimicrobial Peptides RI8 and RW8 Kill MDR Bacteria and Outperform Antibiotics in Pneumonia Model | Research

The takeaway

Symmetric palindromic peptides RI8/RW8 showed broad-spectrum MDR activity (MIC 2-16 μg/mL), protease resistance, dual membrane/DNA targeting, and outperformed levofloxacin for S. aureus pneumonia in mice.

Outperformed levofloxacin
RI8/RW8 achieved 3-5 log bacterial reduction vs 2 logs for levofloxacin in S. aureus pneumonia model

What the researchers found

RI8: MIC 2-16 μg/mL broad-spectrum, therapeutic index 39.4, <1% hemolysis. RW8: protease-resistant, 71.4% biofilm inhibition. Both: dual membrane/DNA mechanism, 2-5 log wound reduction, outperformed levofloxacin in pneumonia (3-5 vs 2 logs).

Why it matters

These peptides solve two major AMP problems: protease degradation and narrow spectrum. Their rational design creates a versatile platform for different infection types.

How the study worked

Rational peptide design with (RRYY)2P(YYRR)2 scaffold, MIC/hemolysis/serum stability assays, MD simulations, biofilm assays, murine MDR wound and S. aureus pneumonia models.

What this study cannot tell us

Mouse models. Manufacturing costs of designed peptides. Long-term resistance development not tested beyond initial assays. Pharmacokinetics need full characterization.

How to read the evidence

Comprehensive rational design study with in vitro, computational, and dual in vivo model validation. Strong translational potential.

When this study was published

Published in 2025.

The bigger picture

The symmetric palindromic scaffold is a general design principle: one peptide architecture, two complementary variants optimized for different clinical scenarios (systemic vs topical).

Questions still open

Could RI8 and RW8 be combined for enhanced efficacy?
Would the palindromic scaffold work with other amino acid sequences?
What is the manufacturing cost at clinical scale?

Common questions

How are these peptides different from other antimicrobial peptides?

They have a unique symmetric, palindromic structure with a proline hinge that allows them to attack bacteria through two mechanisms simultaneously: disrupting cell membranes AND binding DNA. This dual attack makes resistance much harder to develop.

Are they better than antibiotics?

In a mouse pneumonia model, they killed 10-100× more S. aureus bacteria than levofloxacin (a strong antibiotic). They also restored immune function, which antibiotics alone don't do.

Read the original research

Antimicrobial peptides RI8 and RW8 target bacterial membranes and genomic DNA to overcome drug resistance.

Bioorganic chemistry, 172, 109599

View on PubMed ↗Publisher’s paper ↗

Citation

Gao, Ziwei; Zhang, Meng-Yue; Cheng, Yan-Liang; Shi, Yi-Fan; Shan, Xiao-Le; Zhang, Zi-Xuan; Han, Yu-Ling; Li, Shuang. (2026). Antimicrobial peptides RI8 and RW8 target bacterial membranes and genomic DNA to overcome drug resistance.. Bioorganic chemistry, 172, 109599. https://doi.org/10.1016/j.bioorg.2026.109599